Blog
business
4 min read

Export Surge 75%: 5 Reasons K-Beauty Home Devices Are Conquering Japan and the US

K-beauty home beauty device exports surged 75% year-on-year in February 2026, reaching $18.12 million. APR's AGE-R surpassing 6 million units sold and a ninefold explosion in Japan exports signal that the anti-aging boom is thrusting K-beauty to the frontlines of a hardware war.

📷
Image unavailable: Failed to secure a static URL for APR's official product images. Product photos can be found on the APR official site and in KED Global articles.
Why does this matter now? The anti-aging boom has escalated beyond K-cosmetics into a full-blown 'hardware war.' Home beauty device exports jumped 75% year-on-year in February, and the global beauty device market is projected to expand to $89.8 billion by 2030.

TL;DR

  • February 2026 K-beauty home device exports: $18.12 million (+74.9% YoY)
  • Japan exports: $4.9 million — a 9x year-on-year explosion
  • APR AGE-R cumulative sales: surpassed 6 million units
  • Home beauty device market projected to grow at an annualized rate of ~30%
  • Competitors: LG H&H, AmorePacific, Pharma Research, Classys all expanding simultaneously

1. The Facts: Export Explosion by the Numbers

According to data compiled by Hankyung Aicel, domestic beauty device exports in February 2026 totaled $18.12 million (approximately â‚©26 billion), a 74.9% increase from $10.36 million in the same month last year. January exports also recorded double-digit year-on-year growth, confirming a sustained annual growth trend.

The standout market is Japan. February exports to Japan surged to $4.9 million — a 9x year-on-year jump — demonstrating how K-beauty hardware is rapidly absorbing Japanese consumer demand for home care.

2. The Spread Mechanism: Why Is It Booming Now?

The democratization of anti-aging demand is the core driver. RF (radio frequency), microcurrent, and HIFU (high-intensity focused ultrasound) technologies — once exclusive to clinics and dermatology offices — are now built into home care devices, enabling consumers to pursue clinic-level results with products priced in the hundreds of thousands of won.

The GLP-1 obesity drug boom has generated new demand on top of that. The need for lifting devices to address skin sagging after rapid weight loss has emerged as a "complementary essential," creating an entirely new buyer segment.

K-content-linked marketing via social media and live shopping has also hit the accelerator. Influencer "before-and-after" content is driving viral spread and translating directly into purchase decisions among consumers in Japan and the US.

3. Stakeholders: Who Has Entered This War?

CompanyKey Products & Strategy
APRMedicube line including AGE-R Booster Pro — 6 million units sold cumulatively; medical device (EBD) launch planned for H2
LG H&HExpanding home beauty device lineup
AmorePacificDeveloping new hair and scalp care devices
Pharma ResearchStrengthening medical device-based beauty device lineup
ClassysOver 70% of total revenue from overseas — targeting global clinics and hospitals
Jeisys MedicalOverseas revenue share reaches 85%; focused on premium markets in North America and Europe

4. Sustainability Outlook: Temporary Trend or Structural Shift?

According to Samil PwC, the global beauty device market is projected to expand from $14 billion in 2022 to $89.8 billion by 2030. Market research firms forecast that high growth rates of ~30% annually will continue for several years.

Multiple structural growth factors are at play:

  • Accelerating global aging → sustained expansion of anti-aging demand
  • Consumer shift toward "clinic-replacement home care"
  • K-beauty brands' global recognition → greater acceptance of premium pricing
  • Growing number of US FDA-cleared companies → rising adoption rates in Western clinics and hospitals

Near-term risks: Rapid catch-up by competing products from Chinese and Japanese firms; potential contraction in demand for high-priced durable goods if the global economy slows.

5. Secondary Issues: Derivative Topics Checklist

Medical device classification debate: Regulatory issues around classifying RF- and HIFU-based devices as medical vs. general consumer devices — differing approval standards domestically and abroad are increasing export complexity
Data sovereignty: Ethics of collecting and using skin data from AI-powered skin diagnostic devices made by APR and others
Counterfeit risk: Surging global demand → growing concern over proliferation of Chinese-made counterfeit devices
Environmental regulations: Need to prepare for stricter EU sustainability rules on device lifespan and repairability

References


Image credit: Official photo by APR (File photo by APR, via KED Global)

Related Posts